The structure and composition of human placental fibrinoid were studie
d on cryostat and paraffin sections and by transmission electron micro
scopy as well as immunohistochemistry using antibodies directed agains
t fibrin, fibronectin isoforms, collagens IV and VI, laminin and tenas
cin. The findings suggest two structurally and immunohistochemically d
ifferent subtypes of fibrinoid: fibrin-type fibrinoid and matrix-type
fibrinoid. Fibrin-type fibrinoid was characterized by immunoreactivity
for fibrin and cellular fibronectin, including the ED-A sequence. Imm
unostaining for all other extracellular matrix molecules was negative.
Ultrastructurally, this fibrinoid subtype consisted of a meshwork of
fibers with 20-nm cross striation typical of fibrin. Fibrin-type fibri
noid never contained extravillous trophoblast cells. It is therefore p
rimarily a blood clot product derived from maternal and fetal blood. I
n contrast, matrix-type fibrinoid showed virtually no evidence of fibr
in; it was immunopositive for extracellular matrix molecules such as t
he fibronectins, particularly oncofetal fibronectin (containing the ED
-B sequence), collagen IV, laminin and tenascin. Oncofetal fibronectin
, which was neither expressed in fibrin-type fibrinoid nor in the vill
ous stromal core, seemed to be a specific marker for matrix-type fibri
noid. Single or clustered nonproliferative extravillous trophoblast ce
lls were embedded within the matrix molecules. It is very likely that
these cells secrete the matrix in a nonpolarized fashion. Fibrin-type
fibrinoid would appear to be involved in shaping the intervillous spac
e and in replacing damaged syncytiotrophoblast acting as a transport a
nd immune barrier. Matrix-type fibrinoid, as a secretory product of th
e extravillous trophoblast, should be discussed in context with the in
vasive properties of this cell population.